Secher A, Jelsing J, Baquero AF, Hecksher-Sorensen J, Cowley MA, Dalboge LS, Hansen G, Grove KL, Pyke C, Raun K, Schaffer L, Tang-Christensen M, Verma S, Witgen BM, Vrang N, and Bjerre Knudsen L
More serious risks include pancreatitis (requiring immediate medical attention if severe abdominal pain occurs), gallbladder disease, and a boxed warning for medullary thyroid carcinoma risk (contraindicated in patients with personal/family history of MTC or Multiple Endocrine Neoplasia syndrome type 2)
A.StoffersD.et al
Additionally, the Wegovy injection appears to be slightly more effective for weight loss than the Wegovy pill
Caveats: compounded-only, no FDA-approved brand-name path
The GLP-1 injection site guide references 6 mm as the standard recommendation across all common injection sites